This book will bring you up to speed on recent changes to the NDA process — including the change from paper to electronic format — and guide you step-by-step through the application process. Whether you’re an industry veteran or newcomer, this book will help ensure that your new drug does indeed makeit to the marketplace.
Your NDA sets out the conditions that can spell the difference between commercial success and failure. In Preparing the New Drug Application, you’ll get comprehensive guidance on how to:
About the Author
William Sietsema is a senior director at Kendle International. He played a pivotal role in the fast-track development of Pharmacia's Celebrex, which transited from beginning of Phase II to NDA approval in less than three years. He has a PhD in biochemistry from the University of Wisconsin and is the author of two books, one of which was published by FDAnews. He is also a member of the American Chemical Society, the American Society for Bone and Mineral Research, the Inflammation Research Association, the American College of Rheumatology, the Arthritis Foundation, the Endocrine Society and the International Association for the Study of Pain.
Interested in purchasing more than one print copy?
Significant volume discounts are available for ordering three or more copies of the same book. You must order them at the same time and provide a single payment to take advantage of the discount. Order below by clicking submit and then change your quantity in the shopping cart. The discount will be calculated automatically.
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally with any questions.
Interested in Electronic Multi-user Access?
Phone: +1 (703) 538-7600 or toll free (888) 838-5578